The trimodality treatment was possible in 25% of cases with operable disease due to the high rate of patient refusal to proceed to surgery following induction radiochemotherapy. No difference in survival was observed between patients treated with surgery and those treated with radiochemotherapy only because of a limited follow-up. So, the benefit of additional surgery is not clear, and a longer follow-up is needed before final conclusions can be drawn.
Authors: Zafer Koçak, Mert Saynak, Kazım Uygun, Yener Yörük, Alaattin Özen, Necdet Süt, Gündeniz Altıay, Murat Çaloğlu, Altemur Karamustafaoğlu, Ufuk Usta, Hakan Karagöl, Osman Nuri Hatipoğlu
DOI: https://doi.org/10.1177/030089161109700408
Publish Year: 2012
